This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Santoian, E. C. Articles by Kot, P. A. Search for Related Content PubMed PubMed Citation Articles by Santoian, E. C. Articles by Kot, P. A. Social Bookmarking                         What's this?

Effects of Intracellular and Extracellular Calcium Blockers on the Pulmonary Vascular Responses to PGF2 and U46619

Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C.

Allan D. Angerio, Ph.D.

Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C.

Thomas M. Fitzpatrick, Ph.D., M.D.

Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C.

John C. Rose, M.D.

Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C.

Peter W. Ramwell, Ph.D.

Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C.

Peter A. Kot, M.D.

Department of Physiology and Biophysics, Georgetown University Medical Center, Washington, D.C.

In this study, TMB-8, an intracellular calcium antagonist, and verapamil, an extracellular calcium antagonist, were used simultaneously to elucidate the role of calcium in the pulmonary vasopressor response induced by PGF₂ and U46619. The pulmonary vasoconstrictor action of these two agonists was evaluated in the canine isolated lung lobe preparation. Lobar arterial pressure was constantly monitored and changes in arterial pressure were recorded as a percentage from baseline. Control responses to PGF₂ (42.0±8.2%) and U46619 (47.2±7.0%) were obtained prior to the administration of TMB-8 and verapamil. After administration of TMB-8 and verapamil, the PGF₂ (7.4±3.1%) and U46619 (28.8±6.2%) responses were significantly attenutated. We conclude that the PGF₂ pressor response is dependent on a TMB-8-sensitive intracellular calcium pool and a verapamil-sensitive slow-channel calcium influx. In contrast, the degree of attenuation of the U46619 response was similar to the vasopressor response in the presence of verapamil alone, as described previously. This indicates a direct dependence on extracellular calcium. An additional source of calcium insensitive to verapamil and TMB-8 may also be activated and contribute to the pulmonary vasoconstrictor action. These results suggest that each agonist possesses a mechanism of action distinctly different from the other.

Angiology, Vol. 38, No. 1, 51-55 (1987)
DOI: 10.1177/000331978703800107


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?